{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:48Z","timestamp":1787004828564,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1053\/j.seminoncol.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:34:24Z","timestamp":1574123664000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular events in cancer survivors"],"prefix":"10.1053","volume":"46","author":[{"given":"Emily","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Steingart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Teresa Voso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Lo","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Minotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2019.01.007_bib0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3810\/pgm.2010.11.2225","article-title":"Cardiopulmonary exercise testing: relevant but underused","volume":"122","author":"Forman","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0002","series-title":"Measurement of man at work","first-page":"41","article-title":"Temporal factors and physiological load","author":"Bonjer","year":"1971"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0003","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1152\/jappl.1961.16.6.997","article-title":"Cardiorespiratory responses during prolonged exercise","volume":"16","author":"Michael","year":"1961","journal-title":"J Appl Physiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0004","unstructured":"Compendium of Physical Activities. Corrected METs. (2011) https:\/\/sites.google.com\/site\/compendiumofphysicalactivities\/corrected-mets [accessed 13.06.18]."},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2522\/ptj.20110368","article-title":"Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome","volume":"93","author":"Snell","year":"2013","journal-title":"Phys Ther"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0006","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/2047487317709605","article-title":"Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: insights from a multidisciplinary dyspnea center","volume":"24","author":"Huang","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0008","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0009","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","article-title":"Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study","volume":"32","author":"Armstrong","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0011","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2012.43.0702","article-title":"Increased tricuspid regurgitant jet velocity by doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0012","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0013","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","article-title":"Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline","volume":"22","author":"Landier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0014","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0015","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1200\/JCO.2008.21.1441","article-title":"Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort","volume":"27","author":"Nathan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0016","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1200\/JCO.2014.57.3493","article-title":"Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial","volume":"32","author":"Hudson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0017","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2015.04.013","article-title":"Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude Lifetime Cohort Study","volume":"65","author":"Armstrong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0018","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-year survivors of childhood cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0019","article-title":"Integration of CVD prevention into cancer survivorship","author":"Swiger","year":"2016","journal-title":"Am Coll Cardiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.seminoncol.2013.09.010","article-title":"Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management","volume":"40","author":"Steingart","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0021","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2010.09.002","article-title":"ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0022","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0023","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtcvs.2006.09.041","article-title":"Cardiac surgery after mediastinal radiation: extent of exposure influences outcome","volume":"133","author":"Chang","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0024","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2017.02.014","article-title":"Percutaneous revascularization in patients treated with thoracic radiation for cancer","volume":"187","author":"Fender","year":"2017","journal-title":"Am Heart J"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0026","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","article-title":"Asymptomatic cardiac disease following mediastinal irradiation","volume":"42","author":"Heidenreich","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000252","article-title":"Efficacy and follow-up of transcatheter aortic valve implantation in patients with radiation-induced aortic stenosis","volume":"2","author":"Dijos","year":"2015","journal-title":"Open Heart"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0028","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.2010.32.1067","article-title":"Modern approaches to treating acute promyelocytic leukemia","volume":"29","author":"Sanz","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0029","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2010.29.2268","article-title":"Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy","volume":"28","author":"Montesinos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1751-7133.2011.00278.x","article-title":"Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA Protocol","volume":"18","author":"Pellicori","year":"2012","journal-title":"Congest Hear Fail"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0031","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00277-017-3004-z","article-title":"Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin","volume":"96","author":"Rodriguez-Veiga","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0032","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0033","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","article-title":"Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial","volume":"16","author":"Burnett","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2019.01.007_bib0034","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.2014.55.3453","article-title":"Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes","volume":"32","author":"Efficace","year":"2014","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377541930003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377541930003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:54:28Z","timestamp":1758804868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377541930003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S009377541930003X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2019.01.007","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular events in cancer survivors","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}